Search

everythinglearnresearchcommunity

for

Search:↓

The treatment with an oral drug and topical lotion is effective and well-tolerated for hair loss after COVID-19.

Older patients with advanced kidney cancer can be managed with a drug called Sunitinib.

Sex hormones affect reproduction, sexual development, and oral health, and it's important for dental practitioners to understand their effects and interactions.

Severe anti-TNF-α induced scalp eruptions often need stopping the drug and using systemic therapy to avoid scarring.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

Some people with severe hair loss saw hair regrowth after a specific light and drug treatment.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

A hemodialysis patient's hair loss was caused by the drug tinzaparin but stopped after switching to a different drug.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Human hair-derived particles can effectively carry and release the cancer drug Paclitaxel in a pH-sensitive manner, potentially targeting cancer cells while sparing healthy ones.

Topical cyclosporin A may help treat psoriasis but has absorption and side effect challenges.

A man developed skin lesions as a side effect of a gamma secretase inhibitor used for treating a tumor.

The book concludes that despite progress, cancer drug treatments have not met the expectations set in the 1960s and 1970s.

Minoxidil is less effective on eyebrows and eyelashes than scalp hair because these areas have lower enzyme activity needed to activate the drug.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

Two people lost hair unexpectedly after getting a common hair loss treatment with a drug called Dutasteride.

Levetiracetam is widely used and generally well-tolerated for treating idiopathic generalized epilepsies, with tiredness as the main side effect.

A woman developed psoriasis after taking certolizumab pegol, improving after stopping the drug and starting other treatments.

Spironolactone may cause sexual pain and arousal issues in women, which can improve after stopping the drug and using hormone cream.

Minoxidil helps stimulate hair growth and enlarge small follicles in common hair loss, but doesn't stop it, and its effects can be boosted when combined with finasteride.

Minoxidil solution helps regrow hair in men with hair loss, with most improvement seen at 12 months and effects lasting over 30 months.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Lowering the dose of ziprasidone can cause sudden restlessness and urge to move in patients.

PFS might be a delusional disorder with potential to become mass psychogenic illness.

Progesterone and related compounds may help control seizures linked to the menstrual cycle but have limitations that need addressing.

Sorafenib can cause delayed skin problems, so patients need careful monitoring.

Topical minoxidil may slow hair loss but often doesn't lead to satisfactory hair regrowth and requires ongoing treatment.

Some dermatologists in Saudi Arabia prescribe Tofacitinib for hair loss, but many don't due to its unavailability and safety concerns.